- What We Do
- Who We Serve
Since day one, Medacist has been committed to delivering actionable analytics focused on the medication use process to drive better patient safety outcomes for the clients we serve.
Over the past 20+ years, Medacist has continued to be a lead innovator in the healthcare industry and find the solutions to our clients’ needs in the acute care and long term care settings.
Medacist Solutions Group was founded in 1998, as a direct result of extensive consulting projects of its parent company Total Concept Data Services in the healthcare industry. The formation of a healthcare software solutions company was a natural evolution due to an expanding healthcare client base coupled with the unique ability to address a hospital pharmacy’s need for actionable information.
The Genesis analytics platform is built on 20 years of industry exclusive ADS and EMR data from thousands of facilities and intelligence models derived from diversion experience of pattern recognition and confirmed outcomes through machine learning algorithms.
RxAuditor Investigate’s main objective is to target risk within the medication-use-process and identify areas of risk across your organization at any level of responsibility – with a single glance.
In an effort to assist our customers with information pertinent to these shifting practices, we rolled out COVID-19 specific therapeutic analytics and analysis across our solutions. With this implementation of COVID-19 therapeutic analytics, Medacist will provide our customers with a tailored perspective to the Coronavirus practice within their organization.
Medacist launched the Medacist RxDiversion Scorecard, an online set of guidelines to help hospitals and healthcare institutions understand their specific needs and evaluate drug diversion analytical solutions.
Built on stronger data to deliver unparalleled insights, Medacist’s RxAuditor Reconcile closes the loop on the medication use process. Standardized collaborative workflows for drug diversion investigations have the ability to quickly identify anomalous activity.